Noninvasive Assessment of Tumor Cell Proliferation in Animal Models

Neoplasia

Volumn 1, Issue 4, 1999, Pages 303-310

  Edinger, Matthias ^a   Sweeney, Thomas J ^a   Tucker, Amanda A ^a   Olomu, Adesuwa B ^a   Negrin, Robert S ^a   Contag, Christopher H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Imaging; In vivo; Luciferase; Noninvasive monitoring; Therapy; Tumor progression

Indexed keywords

LUCIFERASE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL DIVISION; DIAGNOSTIC IMAGING; EXPERIMENTAL NEOPLASM; GENETIC TRANSFECTION; HELA CELL; HUMAN; KINETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PHOTON; TIME;

ANIMALS; CELL DIVISION; DIAGNOSTIC IMAGING; HELA CELLS; HUMANS; KINETICS; LUCIFERASES; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOTONS; TIME FACTORS; TRANSFECTION;

EID: 0033206335     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900048     Document Type: Article

References (31)

1. Ross BD, Zhao Y-J, Neal ER, Stegman LD, Ercolani M, Ben-Yoseph O, and Chenevert TL (1998). Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci USA 95, 7012-7017.
2. Galons J-P, Altbach Ml, Paine-Murrieta GD, Taylor CW, and Gillies RJ (1999). Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1, 113-117.
3. Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan C-W, Slack M, Sadelain M, Breakefield XO, and Tjuvajev JG (1999). Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1, 154-161.
4. Weissleder R, Tung CH, Mahmood U, and Bogdanov A, Jr. (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17 (4): 375-378.
5. Bogdanov A, Jr., and Weissleder R (1998). The development of in vivo imaging systems to study gene expression. Trends Biotechnol 16 (1): 5-10.
6. Chenevert TL, McKeever PE, and Ross BD (1997). Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3 (9): 1457-1466.
7. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, and Blasberg R (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58 (19): 4333-4341.
8. Uehara H, Miyagawa T, Tjuvajev J, Joshi R, Beattie B, Oku T, Finn R, and Blasberg R (1997). Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions. J Cereb Blood Flow Metab 17 (11): 1239-1253.
9. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, and Blasberg RG (1996). Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56 (18): 4087-4095.
10. Gambhir SS, Barrio JR, Herschman HR, and Phelps ME (1999). Imaging gene expression: principles and assays. J Nucl Cardiol 6 (2): 219-233.
11. Gambhir SS, Barrio JR, Phelps ME, lyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, and Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96 (5): 2333-2338.
12. Hastings JW (1996). Chemistries and colors of bioluminescent reactions: a review. Gene 173 (1): 5-11.
13. Wood KV (1995). Marker proteins for gene expression. Curr Opin Biotechnol 6 (1): 50-58.
14. Willard ST, Faught WJ, and Frawley LS (1997). Real-time monitoring of estrogen-regulated gene expression in single, living breast cancer cells: a new paradigm for the study of molecular dynamics. Cancer Res 57 (20): 4447-4450.
15. Chen H, Biel MA, Borges MW, Thiagalingam A, Nelkin BD, Baylin SB, and Ball DW (1997). Tissue-specific expression of human achaetescute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. Cell Growth Differ 8 (6): 677-686.
16. Takakuwa K, Fujita K, Kikuchi A, Sugaya S, Yahata T, Aida H, Kurabayashi T, Hasegawa I, and Tanaka K (1997). Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues. Jpn J Cancer Res 88 (2): 166-175.
17. Zhang L, Hellstrom KE, and Chen L (1994). Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 12, 87-92.
18. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, and Benaron DA (1995). Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18 (4): 593-603.
19. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, and Benaron DA (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66 (4): 523-531.
20. Chance B, Luo Q, Nioka S, Alsop DC, and Detre JA (1997). Optical investigations of physiology: a study of intrinsic and extrinsic biomedical contrast. Philos Trans R Soc London Ser B 352 (1354): 707-716.
21. Contag PR, Olomu IN, Stevenson DK, and Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med 4 (2): 245-247.
22. Sherf B, and Wood KV (1994). Firefly luciferase engineered for improved genetic reporting. Promega Notes Magazine 49, 14-21.
23. Calmels TP, Mistry JS, Watkins SC, Robbins PD, McGuire R, and Lazo JS (1993). Nuclear localization of bacterial Streptoalloteichus hindus-tanus bleomycin resistance protein in mammalian cells. Mol Phamacol 44 (6): 1135-1141.
24. Shpitz B, Chambers CA, Singhal AB, Hozumi N, Femandes BJ, Roifman CM, Weiner LM, Roder JC, and Gallinger S (1994). High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GMI. J Immunol Methods 169 (1): 1-15.
25. Hirsch-Ginsberg C (1998). Detection of minimal residual disease: relevance for diagnosis and treatment of human malignancies. Annu Rev Med 49, 111-122.
26. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, and Blasberg RG (1995). Imaging the expression of transfected genes in vivo. Cancer Res 55 (24): 6126-6132.
27. Gambhir SS, Barrio JR, Wu L, lyer M, Namavari M, Satyamurthy N, Bauer E, Parrish C, MacLaren DC, Borghei AR, Green LA, Sharfstein S, Berk AJ, Cherry SR, Phelps ME, and Herschman HR (1998). Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 39 (11): 2003-2011.
28. Negrin RS, and Blume KG (1991). The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78 (2): 255-258.
29. Uckun FM, Sather H, Reaman G, Shuster J, Land V, Trigg, M, Gunther R, Chelstrom L, Bleyer A, and Gatynon P (1995). Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 85 (4): 873-878.
30. Uckun FM (1996). Severe combined immunodeficient mouse models of human leukemia. Blood 88 (4): 1135-1146.
31. Hendrikx PJ, Martens CM, Hagenbeek A, Keij JF, and Visser JW (1996). Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol 24 (2): 129-140.